Literature DB >> 31111362

Letter to Editor: Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Behçet disease.

Wang-Dong Xu1, An-Fang Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31111362     DOI： 10.1007/s10067-019-04599-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  5 in total

1.  Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.

Authors:  Eya Bouali; Wajih Kaabachi; Agnes Hamzaoui; Kamel Hamzaoui
Journal:  Immunol Lett       Date:  2015-08-04       Impact factor: 3.685

2.  A possible role for interleukin 37 in the pathogenesis of Behcet's disease.

Authors:  Z Ye; C Wang; A Kijlstra; X Zhou; P Yang
Journal:  Curr Mol Med       Date:  2014-05       Impact factor: 2.222

3.  Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Behçet disease.

Authors:  Selcan Özgüçlü; Türker Duman; Funda Seher Özalp Ateş; Orhan Küçükşahin; Sevgi Çolak; Ümit Ölmez
Journal:  Clin Rheumatol       Date:  2018-09-18       Impact factor: 2.980

4.  Genetic analysis of innate immunity in Behcet's disease identifies an association with IL-37 and IL-18RAP.

Authors:  Handan Tan; Bolin Deng; Hongsong Yu; Yi Yang; Lin Ding; Qi Zhang; Jieying Qin; Aize Kijlstra; Rui Chen; Peizeng Yang
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

Review 5.  Immunopathogenesis of Behcet's Disease.

Authors:  Bainan Tong; Xiaoli Liu; Jun Xiao; Guanfang Su
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.